Zasławski Ryszard, Surowiak Paweł, Paluchowski Piotr, Dziegiel Piotr, Maciejczyk Adam, Pudełko Marek, Wojnar Andrzej, Zabel Maciej
Department of Obstetrics and Gynaecology, Voivodship Hospital, Legnica, Poland.
Folia Morphol (Warsz). 2005 Feb;64(1):9-15.
In case of breast cancer the grade of differentiation and expression of oestrogen and progesterone receptors falls within the first category of prognostic factors according to the College of American Pathologists. HER-2, p53 and Ki67 belong to the second category and their significance still awaits confirmation. The aim of the present study was to examine the relationship between the intensity of expression of oestrogen receptors (ER), progesterone receptors (PgR), HER-2, p53 and Ki67 in cells of ductal breast cancer of G1, G2 or G3 differentiation grade. In paraffin sections of 60 ductal breast cancers (20 cases in G1, 20 in G2 and 20 in G3), immunocytochemical reactions were performed to detect the expression of ER, PgR, HER-2, p53 and Ki67. Following a semi-quantitative appraisal of the preparations under examination, appropriate statistical tests were used to document significant relationships. We noted significant positive correlations between ER and PgR (the entire group studied, G1-3, and the G1 group), HER-2 and p53 (G2) and between p53 and Ki67 expression (G2). Significant negative correlations were found between ER and p53 (G1-3), PgR and p53 (G1-3, G1, G3) and between PgR and Ki67 (G1-3, G2). The studies performed demonstrated distinct relationships between the expression intensity of various proteins in tumour cells in relation to the grade of differentiation of the tumour. We also showed that a parallel determination of ER, PgR and p53 expression may carry high predictive value as to response to tamoxifen treatment.
根据美国病理学家学会的分类,在乳腺癌中,分化程度以及雌激素和孕激素受体的表达属于第一类预后因素。HER-2、p53和Ki67属于第二类,其意义仍有待证实。本研究的目的是探讨雌激素受体(ER)、孕激素受体(PgR)、HER-2、p53和Ki67在G1、G2或G3分化程度的乳腺导管癌细胞中的表达强度之间的关系。在60例乳腺导管癌的石蜡切片(G1组20例、G2组20例、G3组20例)中,进行免疫细胞化学反应以检测ER、PgR、HER-2、p53和Ki67的表达。在对所检查的标本进行半定量评估后,使用适当的统计检验来记录显著的相关性。我们注意到ER与PgR之间(整个研究组、G1-3组以及G1组)、HER-2与p53之间(G2组)以及p53与Ki67表达之间(G2组)存在显著正相关。在ER与p53之间(G1-3组)、PgR与p53之间(G1-3组、G1组、G3组)以及PgR与Ki67之间(G1-3组、G2组)发现显著负相关。所进行的研究表明,肿瘤细胞中各种蛋白质的表达强度与肿瘤的分化程度之间存在明显的关系。我们还表明,同时测定ER、PgR和p53的表达对于他莫昔芬治疗的反应可能具有很高的预测价值。